Clik here to view.
Cold Genesys的枢纽性和联合免疫疗法试验获得B轮投资
加州圣安娜 (美国商业资讯)–临床阶段溶瘤免疫疗法公司Cold Genesys Inc.今天宣布成功完成一笔B轮融资，该融资由Ally Bridge集团和WI Harper集团共同主导，Whitesun Healthcare Ventures和Song Hong Fang也参与其中。该笔内部人士发起的B轮融资为1000万美元，将用于推动Cold...
View ArticleClik here to view.
Asterand Bioscience Acquires AdeptBio LLC
DETROIT Asterand Bioscience, Inc. is pleased to announce the acquisition of AdeptBio LLC, a Memphis-based biobank organization, which specializes in procurement of human tissue specimens. “We are...
View ArticleClik here to view.
Vantage mHealthcare Announces Banking Agreement with China Merchants Bank
NEW YORK Vantage mHealthcare, Inc. (OTCQB:VNTH) (“Vantage Health” or the “Company”) today announced that Nanobeak LLC, its parent company, has engaged China Merchants Bank New York for a private...
View ArticleClik here to view.
Vantage mHealthcare宣布与中国招商银行达成银行服务协议
纽约 (美国商业资讯)–Vantage mHealthcare, Inc. (OTCQB:VNTH)（下称“Vantage Health”或“公司”）今天宣布，其母公司Nanobeak LLC已与中国招商银行纽约分行达成了发行2000万美元私募股权的中国独家服务协议。...
View ArticleClik here to view.
Takeda Announces European Medicines Agency Acceptance of Ixazomib’s Marketing...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application...
View ArticleClik here to view.
Technavio Says the Increase in Exports Will Boost the Turmeric Market in...
LONDON Technavio, a tech-focused research firm, has published a new report on the turmeric market in India which is expected to grow at a CAGR of more than 1% from 2015-2019. According to the latest...
View ArticleClik here to view.
武田薬品、欧州医薬品庁が再発性／難治性の多発性骨髄腫患者に対するイキサゾミブの販売承認申請を受理したと発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ）– 武田薬品工業株式会社(TSE:...
View ArticleClik here to view.
武田宣布，欧洲药品管理局已受理ixazomib用于复发/难治多发性骨髓瘤患者的市场营销授权申请
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(TSE: 4502) 今天宣布，欧洲药品管理局(EMA)已受理ixazomib用于复发/难治多发性骨髓瘤患者的市场营销授权申请(MAA)，ixazomib是口服蛋白酶体抑制剂类研究药物。7月23日，ixazomib进入EMA人用药品委员会(CHMP)的加速审理，加速审理适用于具有重大公共卫生意义的药品，尤其是创新治疗药物。...
View ArticleClik here to view.
Burning Rock and Illumina Collaborate on Molecular Diagnostics for Oncology
GUANGZHOU, China & SAN DIEGO Burning Rock and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement whereby Burning Rock will develop advanced clinical applications...
View ArticleClik here to view.
Amneal Announces New Biosciences Unit with Charles Lucarelli as President
BRIDGEWATER, N.J. Amneal today announced the creation of Amneal Biosciences, a wholly-owned subsidiary of Amneal Pharmaceuticals LLC (www.amneal.com). Amneal Biosciences will focus exclusively on...
View ArticleClik here to view.
巴西A.C.Camargo癌症中心采用Masimo SpHb用于血红蛋白的无创连续监测
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布，巴西圣保罗A.C.Camargo癌症中心 已安装Masimo的无创连续血红蛋白(SpHb®)技术来监测手术患者。...
View ArticleClik here to view.
ブラジルのACカマルゴがんセンターが非侵襲的・連続的ヘモグロビン測定でマシモのSpHb技術を導入
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、ブラジル・サンパウロのACカマルゴがんセンターが外科患者をモニタリングするためにマシモの非侵襲的・連続的ヘモグロビン（SpHb®）測定技術を導入したと発表しました。...
View ArticleClik here to view.
First Australian and Asia/Pacific Hospital to Demonstrate Commitment to New...
MELBOURNE, Australia Alfred Health Radiation Oncology (AHRO), based at The William Buckland Radiotherapy Centre, announced today that it has become the first cancer centre in the Asia and Pacific...
View ArticleClik here to view.
Clik here to view.
大日本住友製薬との共同研究における最初のマイルストーン達成に関するお知らせ
スコットランド・ダンディー ex scientia Ltd.（以下、「エクセンシア」）は大日本住友製薬株式会社（以下、「大日本住友製薬」）との初年度の共同研究において、高次評価試験を進めるに値する最適化化合物を取得したことを発表します。...
View ArticleClik here to view.
Enrollment Begins in Cytori Phase III/Pivotal ADRESU Urinary Incontinence Trial
SAN DIEGO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced that the first patient has been enrolled and treated in the ADRESU trial, a late phase, physician-initiated Japanese clinical trial to...
View ArticleClik here to view.
Yabao Pharmaceuticals and University of South Australia Announce New Joint...
BEIJING & ADELAIDE, Australia One of China’s leading pharmaceutical companies, Yabao Pharmaceutical Co, Inc. (Shanghai Stock Exchange 600351) and South Australia’s largest university, the...
View ArticleClik here to view.
Starpharma Signs Drug Delivery License with AstraZeneca
MELBOURNE, Australia Starpharma (ASX: SPL) (OTCQX: SPHRY) today announced the signing of a licensing agreement with global pharmaceutical company AstraZeneca. The agreement enables the development...
View ArticleClik here to view.
Samples Sought for Caldera Health “Pee in a Pot” Prostate Test
AUCKLAND, New Zealand Men with suspected prostate cancer are being urged to help Caldera Health perfect its urine diagnostic test. Molecular diagnostic firm Caldera Health is in the final stages of...
View ArticleClik here to view.